Oncology Learning Network CME

5 Episodes

Reverse

CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy

2021-11-1901:14:16

This episode outlines treatment barriers associated with the use of BTK inhibitors in CLL/SLL, including adverse events. Earn CME: https://www.naccme.com/oln

Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies

2021-11-1901:13:14

This episode address treatment barriers, adverse events, and healthcare disparities. Earn CME: https://www.naccme.com/oln

Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies

2021-11-1901:14:06

This episode discusses recently approved and emerging therapies in advanced HER2+ breast cancer. Earn CME: https://www.naccme.com/oln

Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy

2021-11-1501:12:59

This episode discusses the latest clinical trial data on current and emerging anti-androgen therapies in castration-resistant PC (CRPC) and hormone-sensitive PC (HSPC). Earn CME: https://www.naccme.com/oln

Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations

2021-11-1001:11:58

This episode identifies the strengths and limitations of molecular testing methodologies and genomic biomarkers for NSCLC identification, prognosis, and risk stratification. Earn CME: https://www.naccme.com/oln

#box-pro-ellipsis-171645094221396{-webkit-line-clamp:2;}Oncology Learning Network CME